Green-top Guidelines
Green-top Guidelines provide systematically developed recommendations which assist clinicians and patients in making decisions about appropriate treatment for specific conditions.
In this section
Obstetrics
Antenatal care
- Antepartum Haemorrhage (No. 63)
- Birth after Previous Caesarean Birth (No. 45)
- Blood Transfusions in Obstetrics (No. 47)
- Care of late intrauterine fetal death and stillbirth (No. 55)
- Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation (No. 73)
- Care of Women with Obesity in Pregnancy (No. 72)
- Epilepsy in Pregnancy (No. 68)
- External Cephalic Version and Reducing the Incidence of Term Breech Presentation (No. 20a)
- Female Genital Mutilation and its Management (No. 53)
- Management of Breech Presentation (No. 20b)
- Management of Monochorionic Twin Pregnancy (No. 51)
- Management of Thyroid Disorders in Pregnancy (No. 76)
- Maternal Collapse in Pregnancy and the Puerperium (No. 56)
- Placenta Praevia and Placenta Accreta: Diagnosis and Management (No. 27a)
- Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management (No. 27)
- Prevention and Management of Postpartum Haemorrhage (No. 52)
- Reduced Fetal Movements (No. 57)
- Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (No. 37a)
-
Severe Pre-eclampsia/Eclampsia, Management (No. 10a)
[Archived] - Small-for-Gestational-Age Fetus and a Growth Restricted Fetus, Investigation and Care (No. 31)
- The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum (No. 69)
- The Management of Women with Red Cell Antibodies during Pregnancy (No. 65)
-
The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis (No. 22)
[Archived] - Thrombosis and Embolism during Pregnancy and the Puerperium: Acute Management (No. 37b)
- Vasa Praevia: Diagnosis and Management (No. 27b)
Antenatal screening
Infections in pregnancy
- Chickenpox in Pregnancy (No. 13)
-
Genital Herpes in Pregnancy, Management (No. 30)
[Archived] -
HIV in Pregnancy, Management (No. 39)
[Archived] - Identification and management of maternal sepsis during and following pregnancy (No. 64)
- Malaria in Pregnancy, Prevention (No. 54a)
- Prevention of Early-onset Group B Streptococcal Disease (No. 36)
- The Diagnosis and Treatment of Malaria in Pregnancy (No. 54b)
Labour and birth
- Assisted Vaginal Birth (No. 26)
- Birth after Previous Caesarean Birth (No. 45)
- Blood Transfusions in Obstetrics (No. 47)
- Care of late intrauterine fetal death and stillbirth (No. 55)
- External Cephalic Version and Reducing the Incidence of Term Breech Presentation (No. 20a)
- Management of Breech Presentation (No. 20b)
- Management of Monochorionic Twin Pregnancy (No. 51)
- Maternal Collapse in Pregnancy and the Puerperium (No. 56)
- Placenta Praevia and Placenta Accreta: Diagnosis and Management (No. 27a)
- Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management (No. 27)
-
Preterm Labour, Tocolytic Drugs (No. 1b)
[Archived] - Prevention and Management of Postpartum Haemorrhage (No. 52)
- Prevention of Early-onset Group B Streptococcal Disease (No. 36)
- Shoulder Dystocia (No. 42)
- Third- and Fourth-degree Perineal Tears, Management (No. 29)
- Umbilical Cord Prolapse (No. 50)
Medical conditions arising in pregnancy
Multiple pregnancy
Pre-existing medical conditions and pregnancy
Preterm birth
-
Antenatal Corticosteroids to Reduce Neonatal Morbidity (No. 7)
[Archived] - Antenatal corticosteroids to reduce neonatal morbidity and mortality (No. 74)
- Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation (No. 73)
-
Cervical Cerclage (No. 60)
[Archived] - Cervical cerclage (No. 75)
-
Preterm Labour, Tocolytic Drugs (No. 1b)
[Archived] -
Preterm Prelabour Rupture of Membranes (No. 44)
[Archived]